Endothelial cell compatibility of fluoroquinolone solutions for intravenous use

International Journal of Clinical Pharmacology and Therapeutics

Volumn 35, Issue 6, 1997, Pages 235-238

  Vorbach, H ^a   Weigel, G ^b   Robibaro, B ^a   Schaumann, R ^a   Hlousek, M ^a   Beil, W J ^a   Griesmacher, A ^b   Georgopoulos, A ^a,b   Graninger, W ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b UNIVERSITY OF VIENNA   (Austria)

Author keywords

Endothelial cell compatibility; Flouroquinolone; Human umbilical venous endothelial cells (HUVEC)

Indexed keywords

ADENOSINE TRIPHOSPHATE; CIPROFLOXACIN; FLEROXACIN; LUCIFERASE; LUCIFERIN; OFLOXACIN; PROSTACYCLIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT; THROMBOXANE A2;

ARTICLE; CELL DAMAGE; CELL VIABILITY; CONTROLLED STUDY; DRUG EFFECT; DRUG SCREENING; DRUG TOLERABILITY; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; INFLAMMATION; INTRAVENOUS DRUG ADMINISTRATION; PHLEBITIS; PROSTAGLANDIN RELEASE; RADIOIMMUNOASSAY; UMBILICAL VEIN; VASCULAR ENDOTHELIUM;

6-KETOPROSTAGLANDIN F1 ALPHA; ADENOSINE TRIPHOSPHATE; ANTI-INFECTIVE AGENTS; CELL SURVIVAL; CELLS, CULTURED; CIPROFLOXACIN; ENDOTHELIUM, VASCULAR; EPOPROSTENOL; FIREFLY LUCIFERIN; FLEROXACIN; HUMANS; INJECTIONS, INTRAVENOUS; LUCIFERASES; OFLOXACIN; RADIOIMMUNOASSAY; THROMBOXANE A2; UMBILICAL VEINS;

EID: 0030977490     PISSN: 09461965     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Acevedo A, Schoop W, Schnell A, Toledo T 1990 Antibiotic treatment for diabetic foot. Advantages of intravenous regional route as alternative for systemic route. Rev Med Chi 118: 881-888
2. Christ W, Lehnert T, Ulbrich B 1988 Specific toxicologic aspects of the fluoroquinolones. Rev Infect Dis 10 (Suppl 1): 141-146
3. Forgue ST, Shyu WC, Gleason CR, Pittman KA, Barbhaiya RH 1987 Pharmacokinetics of the novel cephalosporin cefepime (BMY-28142) in rats and monkeys. Antimicrob Agents Chemother 31: 799-804
4. Forsgren A, Bredberg A, Riesbeck K 1989 New quinolones: in vitro effects as a potential source of clinical toxicity. Rev Infect Dis 11 (Suppl 5): 1382-1389
5. Gelfand MS, Simmons BP, Craft RB, Grogan J, Amarshi N 1993 A sequential study of intravenous and oral fleroxacin in the treatment of complicated urinary tract infection. Am J Med 94: 126-130
6. 2 synthesis by human endothelial cells. Arterioscler Thromb 12: 512-518
7. Griesmacher A, Weigel G, David M, Schimke I, Mueller MM 1992 Influence of oxygen radicals generating agents on eicosanoid metabolism of human endothelial cells. Thromb Res 65: 721-731
8. Griesmacher A, Weigel G, Windischbauer A, Mueller MM 1991 Purine metabolism in human endothelial cells. Int J Purine Pyrimidine Res 2: 23-127
9. Haudenschild CC, Cotran RS, Gimbrone MA, Folkman J 1975 Fine structure of vascular endothelium in culture. J Ultrastruct Res 50: 22-34
10. Hooper DC, Wolfson JS 1991 Fluoroquinolone antimicrobial agents. N Engl J Med 324: 384-394
11. Hooper DC, Wolfson JS 1993 Quinolone Antimicrobial Agents (2nd edn). American Society for Microbiology, Washington, DC
12. Jaffe EA, Hoyer LW, Nachman RL 1973 Synthesis of antihaemophilic factor antigen by human endothelial cells. J Clin Invest 52: 2757-2763
13. Jaffe EA, Nachman RL, Becker CG, Minck CR 1973 Culture of human endothelial cells derived from umbilical veins. J Clin Invest 52: 2745-2756
14. Neu HC, Davidson S, Briones F 1989 Intravenous/oral ciprofloxacin therapy of infections caused by multiresistant bacteria. Am J Med 87: 209-212
15. Physicians' Desk Reference 1994 Floxin for intravenous infusion 48: 1352-1357
16. Schoop W, Acevedo A 1993 Antibiotic concentrations after intravenous and retrograde intravenous injections. Wien Med Wochenschr 143: 199-200
17. Schopf G, Rumpold H, Mueller MM 1986 Alterations of purine salvage pathways during differentiation of rat heart myoblasts towards myocytes. Biochim Biophys Acta 884: 319-327
18. Thorsteinsson SB, Bergan T, Johannesson G, Thorsteinsson HS, Rohwedder R 1987 Tolerance of ciprofloxacin at injection site, systemic safety and effect on electroencephalogram. Chemotherapy 33: 448-451
19. Thorsteinsson SB, Rahm V, Bergan T 1989 Tolerance of intravenous ciprofloxacin. Scand J Infect Dis Suppl 60: 116-119
20. Weigel G, Griesmacher A, Mueller MM 1991 Regulation of eicosanoid release in human umbilical vein endothelial cells. Thromb Res 62: 685-695